AAN 2025

April 05-09, 2025
San Diego

77th Annual Meeting of the American Academy of Neurology
Explore more Sleep congress materials
Material Type

Results(7)

Neuroscience
Effectiveness and Safety of Low-Sodium Oxybate in Participants With Narcolepsy or Idiopathic Hypersomnia: Top-line Results From the Phase 4 DUET Study
Author(s): Logan D. Schneider, David T. Plante, Deborah A. Nichols et al.
Caregiver-Reported Real-World Use of Cannabidiol (CBD) and Effects on Seizures and Caregiver Burden: Results From the CARE-EpiC Survey
Author(s): Sheila M. Thomas, James McAuley, Christopher Jones et al.
Self-Reported Cognitive Complaints and Work Productivity in Participants With Narcolepsy or Idiopathic Hypersomnia After Low-Sodium Oxybate Treatment: Results From the Phase 4 DUET Study
Author(s): Logan D. Schneider, Chad M. Ruoff, Deborah A. Nichols et al.
Tuberous Sclerosis Complex (TSC)–Associated Neuropsychiatric Disorder (TAND) Outcomes Following Add-on Cannabidiol (CBD) Treatment: 3-Month Analysis of Open-Label Phase 3b/4 Trial EpiCom
Author(s): Agnies van Eeghen, Sarah M.L. Wilson, Douglas M. Smith et al.
Efficacy and Safety of Low-Sodium Oxybate in Narcolepsy Patients With/Without Psychiatric/Neurologic Comorbidities
Author(s): Craig Chepke, Andrew J. Cutler, Nathaniel F. Watson et al.
Dosing Patterns and Persistence on Cannabidiol (CBD): Insights From US Specialty Pharmacy Data
Author(s): Gerhardt Pohl, Leah Burn, Shuo (Serena) Cao et al.
Nurse-Reported Outcomes of Cannabidiol (CBD) Treatment in the Long-Term Care (LTC) Setting: Results From the BECOME-LTC Survey
Author(s): Nanette Wrobel, Jason Shafrin, Andrea Chung et al.